Vaxcell-Bio Therapeutics (Korea) Price on November 27, 2024

323990 Stock  KRW 11,400  230.00  2.06%   
If you're considering investing in Vaxcell-Bio Stock, it is important to understand the factors that can impact its price. As of today, the current price of Vaxcell-Bio Therapeutics stands at 11,400, as last reported on the 11th of December 2024, with the highest price reaching 11,740 and the lowest price hitting 11,130 during the day. Vaxcell-Bio Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.11, which indicates the firm had a -0.11% return per unit of risk over the last 3 months. Vaxcell Bio Therapeutics Co exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Vaxcell-Bio Therapeutics' Risk Adjusted Performance of (0.14), coefficient of variation of (491.45), and Variance of 6.4 to confirm the risk estimate we provide.
  
Vaxcell-Bio Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1095

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns323990

Estimated Market Risk

 2.72
  actual daily
24
76% of assets are more volatile

Expected Return

 -0.3
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.11
  actual daily
0
Most of other assets perform better
Based on monthly moving average Vaxcell-Bio Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vaxcell-Bio Therapeutics by adding Vaxcell-Bio Therapeutics to a well-diversified portfolio.

Vaxcell-Bio Therapeutics Valuation on November 27, 2024

It is possible to determine the worth of Vaxcell-Bio Therapeutics on a given historical date. On November 27, 2024 Vaxcell-Bio was worth 12720.0 at the beginning of the trading date compared to the closed value of 12810.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Vaxcell-Bio Therapeutics stock. Still, in general, we apply an absolute valuation method to find Vaxcell-Bio Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Vaxcell-Bio Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Vaxcell-Bio Therapeutics' related companies.
 Open High Low Close Volume
  12,610    12,800    12,500    12,740    61,226  
11/27/2024
  12,720    12,850    12,540    12,810    64,508  
  12,930    13,480    12,710    12,950    126,578  
Backtest Vaxcell-Bio Therapeutics  |  Vaxcell-Bio Therapeutics History  |  Vaxcell-Bio Therapeutics Valuation   PreviousNext  
Open Value
12720.0
12,712
Downside
12810.0
Closing Value
12,728
Upside

Vaxcell-Bio Therapeutics Trading Date Momentum on November 27, 2024

On November 28 2024 Vaxcell Bio Therapeutics Co was traded for  12,950  at the closing time. The highest price during the trading period was 13,480  and the lowest recorded bid was listed for  12,710 . The volume for the day was 126.6 K. This history from November 28, 2024 contributed to the next trading day price jump. The daily price change to the next closing price was 1.09% . The trading price change to the current price is 9.84% .

Vaxcell-Bio Therapeutics Fundamentals Correlations and Trends

By evaluating Vaxcell-Bio Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Vaxcell-Bio Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Vaxcell-Bio financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Vaxcell-Bio Therapeutics Stock history

Vaxcell-Bio Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Vaxcell-Bio is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Vaxcell-Bio Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Vaxcell-Bio Therapeutics stock prices may prove useful in developing a viable investing in Vaxcell-Bio Therapeutics
Vaxcell-Bio Therapeutics Co., Ltd. develops and sells cancer immune cell therapy products in South Korea. The company was founded in 2010 and is headquartered in Hwasun-eup, South Korea. Vaxcell Bio is traded on Korean Securities Dealers Automated Quotations in South Korea.

Vaxcell-Bio Therapeutics Stock Technical Analysis

Vaxcell-Bio Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Vaxcell-Bio Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Vaxcell-Bio Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Vaxcell-Bio Therapeutics Period Price Range

Low
December 11, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Vaxcell Bio Therapeutics Co cannot be verified against its exchange. Please verify the symbol is currently traded on KOSDAQ. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Vaxcell-Bio Therapeutics December 11, 2024 Market Strength

Market strength indicators help investors to evaluate how Vaxcell-Bio Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vaxcell-Bio Therapeutics shares will generate the highest return on investment. By undertsting and applying Vaxcell-Bio Therapeutics stock market strength indicators, traders can identify Vaxcell Bio Therapeutics Co entry and exit signals to maximize returns

Vaxcell-Bio Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Vaxcell-Bio Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Vaxcell-Bio Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Vaxcell-Bio to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Vaxcell-Bio Stock analysis

When running Vaxcell-Bio Therapeutics' price analysis, check to measure Vaxcell-Bio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxcell-Bio Therapeutics is operating at the current time. Most of Vaxcell-Bio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vaxcell-Bio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxcell-Bio Therapeutics' price. Additionally, you may evaluate how the addition of Vaxcell-Bio Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments